A Novel Preparation Method for Drug Nanocrystals and Characterization by Ultrasonic Spray-assisted Electrostatic Adsorption
Overview
Affiliations
Purpose: The purpose of this study was to develop a novel and continuous method for preparing a nanosized particle of drug crystals and to characterize its properties.
Materials And Methods: A new apparatus was introduced to crystallize nanosized drug crystals of amitriptyline hydrochloride as a model drug. The samples were prepared in the pure state by ultrasonic spray, and elaborated deposition was completed via electrostatic adsorption. Scanning electron microscopy, X-ray powder diffraction, and atomic force microscopy were used to characterize the size of the particles; this was subsequently followed by differential scanning calorimetry.
Results And Discussion: Nanoparticles of drug crystals were successfully prepared. The size of the drug crystals ranged from 20 nm to 400 nm; the particle size of amitriptyline hydrochloride was approximately 71 nm. The particles were spherical and rectangular in shape. Moreover, the melting point of the nanoparticles decreased from 198.2°C to 196.3°C when compared to raw particle crystals. Furthermore, the agglomeration effect was also attenuated as a result of electrostatic repulsion among each particle when absorbed, and depositing on the inner wall of the gathering unit occurred under the electrostatic effect.
Conclusion: Ultrasonic spray-assisted electrostatic adsorption is a very effective and continuous method to produce drug nanocrystals. This method can be applied to poorly water-soluble drugs, and it can also be a very effective alternative for industrial production. Once the working parameters are given, drug nanocrystals will be produced continuously.
Valadez-Lemus R, Gongora-Alfaro J, Jimenez-Vargas J, Alamilla J, Mendoza-Munoz N PLoS One. 2025; 20(2):e0316389.
PMID: 40019891 PMC: 11870345. DOI: 10.1371/journal.pone.0316389.
Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques.
Peltonen L Pharmaceutics. 2018; 10(3).
PMID: 30044395 PMC: 6161287. DOI: 10.3390/pharmaceutics10030104.
Nanomedicine applications in women's health: state of the art.
Lloyd-Parry O, Downing C, Aleisaei E, Jones C, Coward K Int J Nanomedicine. 2018; 13:1963-1983.
PMID: 29636611 PMC: 5880180. DOI: 10.2147/IJN.S97572.
Abdelbary A, Al-Mahallawi A, Abdelrahim M, Ali A Int J Nanomedicine. 2015; 10:6339-53.
PMID: 26491298 PMC: 4608592. DOI: 10.2147/IJN.S91631.
Sun Y, Zhang Y, Shi C, Li W, Chen G, Wang X Hum Vaccin Immunother. 2014; 10(8):2503-6.
PMID: 25424963 PMC: 4896776. DOI: 10.4161/hv.29201.